Colbert Packaging captures orphaned pharma insert market with second Vijuk folding system

Colbert Packaging captures orphaned pharma insert market with second Vijuk folding system

Colbert Packaging expands its microfolded insert capacity with a new G&K Vijuk MVII RTA system, countering the industry trend of exiting IFU production.

August 13, 2026
5 min read

A Strategic Counter-Move in Pharmaceutical Packaging

As we move through the second half of 2026, a peculiar divergence is unfolding within the pharmaceutical packaging sector. While global demand for medical products and their accompanying compliance documentation continues to rise, a significant number of packaging converters are quietly exiting the production of microfolded inserts and Instructions for Use (IFUs). The margins can be tight, and the technical demands of high-speed microfolding are notoriously unforgiving. Yet, where others see a burden, Colbert Packaging Corporation sees a strategic vacuum waiting to be filled.

The Kenosha, Wisconsin-based manufacturer has officially doubled down on its secondary packaging capabilities by investing in a second G&K Vijuk MVII RTA outsert folding system. This capital expenditure is not merely an equipment upgrade; it is a calculated market play to capture the specialty packaging needs of pharmaceutical, healthcare, and consumer packaged goods (CPG) clients who are suddenly finding themselves with fewer reliable supply chain partners.

The Technical Reality of Microfolded Inserts

Microfolding is not for the faint of heart in the converting industry. It requires immense precision to manage paper memory, scoring, and gluing at high speeds without causing catastrophic jams. The newly installed G&K Vijuk MVII RTA system is specifically engineered to handle these exact pain points. Equipped with a double-knife outsert attachment, the machine is tailored for the complexity of pharmaceutical RTA (right turn angle) style outserts.

For industry professionals, the specifications of this equipment highlight a commitment to uninterrupted throughput. The fully programmable system features:

  • An integrated precision glue system for secure outsert closure.
  • A motorized transport system between fold stations to maintain alignment.
  • Advanced jam detection and a heavy-duty scoring system to prevent material waste.
  • A vertical stacking system and ejection device for streamlined end-of-line processing.

By bringing a second unit online, @ColbertPackaging is effectively eliminating bottlenecks in its Kenosha facility, ensuring that high-capacity insert throughput can meet the strict turnaround times demanded by the pharma sector.

Capitalizing on Industry Consolidation

The broader context of this investment is rooted in the ongoing consolidation of the packaging industry. Mergers and acquisitions often lead to the rationalization of product lines, with larger conglomerates shedding niche, high-maintenance operations like IFU production in favor of higher-margin folding cartons or flexible packaging.

Ryan Hart, VP of Sales and Marketing at Colbert Packaging, recently articulated this dynamic, noting that the company's management team actively chose to increase capacity precisely because other suppliers are withdrawing from the insert manufacturing space. This contrarian approach secures Colbert's position as a comprehensive, one-stop provider for secondary packaging. When a pharmaceutical client needs both the folding carton and the legally required compliance insert, Colbert can guarantee the delivery of both without relying on third-party insert specialists.

Looking Ahead: The Future of Secondary Pharma Packaging

The global pharmaceutical packaging market is on a relentless upward trajectory, projected by industry analysts to surpass USD 350 billion by 2033. As regulatory bodies worldwide enforce stricter guidelines on patient information and product traceability, the physical IFU remains a non-negotiable component of the secondary packaging ecosystem, even in an increasingly digital world.

Colbert's investment in 2026 ensures they are well-positioned for the demands of 2027 and beyond. By securing the necessary hardware to produce safe, smart, and sustainable secondary packaging, the company is building a moat around its healthcare portfolio. It is a classic example of how targeted capital expenditure in specialized machinery can yield significant competitive advantages in a consolidating market.

Taking ownership of a difficult niche is often the most reliable path to long-term customer loyalty in the converting sector. Will other mid-sized converters follow Colbert's lead and reclaim the specialized processes that industry giants are leaving behind? Follow The Paper for daily news, market signals and key updates from the global paper, corrugated and packaging industry. — Sigue toda la actualidad del sector en www.thepaper.ai

Enjoying this article?

Register free to save and share.

Tags

#Colbert Packaging
#G&K Vijuk
#pharmaceutical packaging
#microfolded inserts
#IFU
#embalaje secundario
#outserts
#Kenosha
#converting
#paperboard